Pirinixil

This classification denotes an anti-lipidemic agent with the molecular formula C16H19ClN4O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 969LVT6GJ2, chemically known as 2-((4-chloro-6-(2,3-xylidino)-2-pyrimidinyl)thio)-n-(2-hydroxyethyl)acetamide but generally known as pirinixil, which bears US NIH Compound Identifier 68851. European Medicines Agency schedules Pirinixil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09916MIG. The term PIRINIXIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 33, No. 10 1979, List 19). PIRINIXIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule pirinixil under HS 29335995 and SITC 51576. As of Q4 2014, PIRINIXIL remains the US FDA Preferred Term for this commodity. Pirinixil bears US NLM identifiers UMLS ID C0137120 and NCI Concept Code C66424. SMILES: Clc1nc(SCC(=O)NCCO)nc(Nc2c(c(ccc2)C)C)c1.